Skip to main content
Livermore
Livermore
ZHEN

Carnegie Mellon University

SEC CIK
0001039067
Latest filing
Aug 12, 2026

The latest 13F from Carnegie Mellon University covers Q2 2026 (filed Aug 12, 2026): 5 long positions worth $78.9M. The top 10 holdings make up 100.0% of the portfolio, and the largest is Invesco QQQ Trust Series I at 57.0%. Livermore has 19 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
0
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. Invesco QQQ Trust Series I46090E103
    57.0%$45.0M
  2. DUOLDuolingo, Inc.
    43.0%$33.9MHistory
  3. IHTInnsuites Hospitality Trust
    <0.1%$17.0KHistory
  4. AGPUAxe Compute Inc.
    <0.1%$5.24KHistory
  5. XAGELongevity Health Holdings, Inc.
    <0.1%$1.17KHistory

Share of portfolio

Each position's share of portfolio value

  1. Invesco QQQ Trust Series I57.0%
  2. DUOL43.0%
  3. IHT<0.1%
  4. AGPU<0.1%
  5. XAGE<0.1%

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

None this quarter.

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

None this quarter.

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$78.9M
+$14.6M (+22.7%) vs. prior quarter
Positions
5
0 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
0.0%
Q2 2026, one quarter
Average holding period
12.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

19 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $250.0M (Q4 2021)

Q4 2021: $250.0MQ1 2022: $239.1MQ2 2022: $198.9MQ3 2022: $179.5MQ4 2022: $182.6MQ1 2023: $149.6MQ2 2023: $71.0MQ3 2023: $78.8MQ4 2023: $82.9MQ1 2024: $80.1MQ2 2024: $73.9MQ3 2024: $96.9MQ4 2024: $136.7MQ1 2025: $129.0MQ2 2025: $154.6MQ3 2025: $131.6MQ4 2025: $89.3MQ1 2026: $64.3MQ2 2026: $78.9M
Q4 2021Q2 2026
13F filings of Carnegie Mellon University by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 12, 20265$78.9MInvesco QQQ Trust Series IDUOLIHTvs. Q1 2026SEC
Q1 2026May 13, 20265$64.3MInvesco QQQ Trust Series IDUOLIHTvs. Q4 2025SEC
Q4 2025Jan 28, 20265$89.3MDUOLInvesco QQQ Trust Series IIHTvs. Q3 2025SEC
Q3 2025Nov 13, 20255$131.6MDUOLInvesco QQQ Trust Series IIHTvs. Q2 2025SEC
Q2 2025Aug 7, 20255$154.6MDUOLInvesco QQQ Trust Series IIHTvs. Q1 2025SEC
Q1 2025May 5, 20256$129.0MDUOLInvesco QQQ Trust Series IPDDvs. Q4 2024SEC
Q4 2024Feb 7, 20256$136.7MDUOLInvesco QQQ Trust Series IPDDvs. Q3 2024SEC
Q3 2024Nov 13, 20244$96.9MDUOLXAGEIHTvs. Q2 2024SEC
Q2 2024Aug 8, 20244$73.9MDUOLXAGEIHTvs. Q1 2024SEC
Q1 2024May 7, 20246$80.1MDUOLVERAXAGEvs. Q4 2023SEC
Q4 2023Feb 2, 20246$82.9MDUOLXAGEVERAvs. Q3 2023SEC
Q3 2023Nov 1, 20237$78.8MDUOLiShares Core MSCI Emerging Markets ETFXAGEvs. Q2 2023SEC
Q2 2023Aug 1, 20236$71.0MDUOLiShares Core MSCI Emerging Markets ETFVERAvs. Q1 2023SEC
Q1 2023May 3, 20236$149.6MiShares Core MSCI Emerging Markets ETFDUOLNBSEvs. Q4 2022SEC
Q4 2022Feb 7, 20236$182.6MiShares Core MSCI Emerging Markets ETFDUOLVERAvs. Q3 2022SEC
Q3 2022Nov 10, 20226$179.5MiShares Core MSCI Emerging Markets ETFDUOLNBSEvs. Q2 2022SEC
Q2 2022Aug 5, 20226$198.9MiShares Core MSCI Emerging Markets ETFDUOLNBSEvs. Q1 2022SEC
Q1 2022May 10, 20226$239.1MiShares Core MSCI Emerging Markets ETFDUOLNBSEvs. Q4 2021SEC
Q4 2021Feb 11, 20226$250.0MiShares Core MSCI Emerging Markets ETFDUOLNBSE–SEC